By extracting detailed clinical and pathological data from case reports and series, we revealed the real-world diversity of tumors that express TA-MUC1, ranging from common gastrointestinal cancers to rare tumors such as sarcomatoid carcinomas, mesotheliomas, and adrenal metastases. Here, MUC1 is linked to sarcomatoid carcinoma.